In the CD3/CD19 subset, one patient presented with growth retardation while another suffered from hypogonadism and hypothyroidism following TBI treated with hormone replacement therapy, as well as CsA-associated osteoporosis. The gene discussed is CD19; the disease is hypogonadism.